Ignite Creation Date:
2025-12-24 @ 5:07 PM
Ignite Modification Date:
2025-12-29 @ 7:22 PM
Study NCT ID:
NCT05689450
Status:
COMPLETED
Last Update Posted:
2024-02-21
First Post:
2023-01-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder
Sponsor:
University Hospital, Basel, Switzerland
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2022-01218; am23Osthoff
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None